Canakinumab
ATC L04AC08 · 10 markets · 17 records
US 3 records · 2 strengths
- 150 mginjectionIlarisManufacturer: Novartis Pharma Stein AG
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 3 records · 2 strengths
- 150 mginjectionIlaris 150mg powder for solution for injection vials
- 150 mg/1 mLinjectionIlaris 150mg/1ml solution for injection pre-filled pensIlaris 150mg/1ml solution for injection vials
AU 2 records · 2 strengths
- 150 mginjectionILARIS canakinumab 150mg/1mL solution for injection in vials
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CA 1 records · 1 strengths
- 150 mgliquidIlaris
ES 1 records · 1 strengths
- 150 mg/1 mLinjectionIlaris
TW 1 records · 1 strengths
- 150 mginjectionIlaris 150mg/mL solution for易來力注射液150毫克/毫升
HK 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 strengths
- 150 mg/1 mLinjectionILARIS 150 mg/ml, solution injectable
| Strength / form / release | US | GB | CA | AU | ES | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|
| 150 mg injection | Manufacturer: Novartis Pharma Stein AG Ilaris | Ilaris 150mg powder for solution for injection vials | ILARIS canakinumab 150mg/1mL solution for injection in vials | Ilaris 150mg/mL solution for 易來力注射液150毫克/毫升 | |||||
| 150 mg/1 mL injection | Ilaris 150mg/1ml solution for injection pre-filled pens Ilaris 150mg/1ml solution for injection vials | Ilaris | ILARIS 150 mg/ml, solution injectable | ||||||
| 150 mg liquid | Ilaris | ||||||||
unknown | Ilaris | ILARIS SOLUTION FOR INJECTION 150MG/ML | Ilaris | ||||||
liquid | GUNA-ANTI IL 1 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in CA and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en CA que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 CA 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 CA 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.